{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:20Z","timestamp":1772119760019,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11102-024-01431-x","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T02:02:36Z","timestamp":1722045756000},"page":"577-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas"],"prefix":"10.1007","volume":"27","author":[{"given":"Roel","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Massman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarai","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Cheok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Mrachek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Coss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana G.","family":"Ioachimescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Zwagerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Olivier-Van Stichelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11102-018-0869-3","volume":"21","author":"G Ntali","year":"2018","unstructured":"Ntali G, Wass JA (2018) Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21:111\u2013118. https:\/\/doi.org\/10.1007\/s11102-018-0869-3","journal-title":"Pituitary"},{"key":"1431_CR2","doi-asserted-by":"publisher","first-page":"W512","DOI":"10.2214\/AJR.15.14527","volume":"205","author":"IH Lee","year":"2015","unstructured":"Lee IH, Miller NR, Zan E et al (2015) Visual defects in patients with Pituitary adenomas: the myth of Bitemporal Hemianopsia. AJR Am J Roentgenol 205:W512\u2013518. https:\/\/doi.org\/10.2214\/AJR.15.14527","journal-title":"AJR Am J Roentgenol"},{"key":"1431_CR3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3171\/JNS\/2008\/108\/4\/0736","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang EF, Zada G, Kim S et al (2008) Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg 108:736\u2013745. https:\/\/doi.org\/10.3171\/JNS\/2008\/108\/4\/0736","journal-title":"J Neurosurg"},{"key":"1431_CR4","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI20401","volume":"112","author":"S Melmed","year":"2003","unstructured":"Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112:1603\u20131618. https:\/\/doi.org\/10.1172\/JCI20401","journal-title":"J Clin Invest"},{"key":"1431_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/jama.2023.5444","volume":"329","author":"NA Tritos","year":"2023","unstructured":"Tritos NA, Miller KK (2023) Diagnosis and management of Pituitary adenomas: a review. JAMA 329:1386\u20131398. https:\/\/doi.org\/10.1001\/jama.2023.5444","journal-title":"JAMA"},{"key":"1431_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-90475-3","volume-title":"Pituitary adenomas: the European Neuroendocrine Association\u2019s young researcher Committee Overview","author":"G Tamagno","year":"2022","unstructured":"Tamagno G, Gahete MD (2022) Pituitary adenomas: the European Neuroendocrine Association\u2019s young researcher Committee Overview. Springer International Publishing, Cham"},{"key":"1431_CR7","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"1431_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1210\/er.2012-1013","volume":"34","author":"A Beckers","year":"2013","unstructured":"Beckers A, Aaltonen LA, Daly AF, Karhu A (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34:239\u2013277. https:\/\/doi.org\/10.1210\/er.2012-1013","journal-title":"Endocr Rev"},{"key":"1431_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s11102-019-00982-8","volume":"22","author":"AL Pappy","year":"2019","unstructured":"Pappy AL, Savinkina A, Bicknese C et al (2019) Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients. Pituitary 22:520\u2013531. https:\/\/doi.org\/10.1007\/s11102-019-00982-8","journal-title":"Pituitary"},{"key":"1431_CR10","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A et al (2018) European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178:G1\u2013G24. https:\/\/doi.org\/10.1530\/EJE-17-0796","journal-title":"Eur J Endocrinol"},{"key":"1431_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev-nutr-071812-161240","volume":"33","author":"MR Bond","year":"2013","unstructured":"Bond MR, Hanover JA (2013) O-GlcNAc cycling: a link between metabolism and chronic disease. Annu Rev Nutr 33:205\u2013229. https:\/\/doi.org\/10.1146\/annurev-nutr-071812-161240","journal-title":"Annu Rev Nutr"},{"key":"1431_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fendo.2014.00183","volume":"5","author":"GW Hart","year":"2014","unstructured":"Hart GW (2014) Three decades of research on O-GlcNAcylation - A major nutrient Sensor that regulates signaling, transcription and Cellular Metabolism. Front Endocrinol 5:183. https:\/\/doi.org\/10.3389\/fendo.2014.00183","journal-title":"Front Endocrinol"},{"key":"1431_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41597-021-00810-4","volume":"8","author":"E Wulff-Fuentes","year":"2021","unstructured":"Wulff-Fuentes E, Berendt RR, Massman L et al (2021) The human O-GlcNAcome database and meta-analysis. Sci Data 8:25. https:\/\/doi.org\/10.1038\/s41597-021-00810-4","journal-title":"Sci Data"},{"key":"1431_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10863-018-9751-2","volume":"50","author":"JA Hanover","year":"2018","unstructured":"Hanover JA, Chen W, Bond MR (2018) O-GlcNAc in cancer: an oncometabolism-fueled vicious cycle. J Bioenerg Biomembr 50:155\u2013173. https:\/\/doi.org\/10.1007\/s10863-018-9751-2","journal-title":"J Bioenerg Biomembr"},{"key":"1431_CR15","doi-asserted-by":"publisher","first-page":"bqab178","DOI":"10.1210\/endocr\/bqab178","volume":"162","author":"LJ Massman","year":"2021","unstructured":"Massman LJ, Pereckas M, Zwagerman NT, Olivier-Van Stichelen S (2021) O-GlcNAcylation is essential for Rapid Pomc expression and cell proliferation in Corticotropic Tumor cells. Endocrinology 162:bqab178. https:\/\/doi.org\/10.1210\/endocr\/bqab178","journal-title":"Endocrinology"},{"key":"1431_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19:722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Rev Endocrinol"},{"key":"1431_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9:847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1431_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013617 discussion 617\u2013618. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"key":"1431_CR19","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.celrep.2017.07.017","volume":"20","author":"S-K Park","year":"2017","unstructured":"Park S-K, Zhou X, Pendleton KE et al (2017) A conserved splicing silencer dynamically regulates O-GlcNAc transferase Intron Retention and O-GlcNAc Homeostasis. Cell Rep 20:1088\u20131099. https:\/\/doi.org\/10.1016\/j.celrep.2017.07.017","journal-title":"Cell Rep"},{"key":"1431_CR20","doi-asserted-by":"publisher","first-page":"105344","DOI":"10.1016\/j.jbc.2023.105344","volume":"299","author":"G Le Minh","year":"2023","unstructured":"Le Minh G, Esquea EM, Young RG et al (2023) On a sugar high: role of O-GlcNAcylation in cancer. J Biol Chem 299:105344. https:\/\/doi.org\/10.1016\/j.jbc.2023.105344","journal-title":"J Biol Chem"},{"key":"1431_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB et al (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43:1003\u20131037. https:\/\/doi.org\/10.1210\/endrev\/bnac010","journal-title":"Endocr Rev"},{"key":"1431_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10020-022-00544-y","volume":"28","author":"Q Lu","year":"2022","unstructured":"Lu Q, Zhang X, Liang T, Bai X (2022) O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy. Mol Med Camb Mass 28:115. https:\/\/doi.org\/10.1186\/s10020-022-00544-y","journal-title":"Mol Med Camb Mass"},{"key":"1431_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fendo.2018.00415","volume":"9","author":"C Liu","year":"2018","unstructured":"Liu C, Li J (2018) O-GlcNAc: a sweetheart of the cell cycle and DNA damage response. Front Endocrinol 9:415. https:\/\/doi.org\/10.3389\/fendo.2018.00415","journal-title":"Front Endocrinol"},{"key":"1431_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3892\/ol.2016.4647","volume":"12","author":"YU Cheng","year":"2016","unstructured":"Cheng YU, Li H, Li J et al (2016) O-GlcNAcylation enhances anaplastic thyroid carcinoma malignancy. Oncol Lett 12:572\u2013578. https:\/\/doi.org\/10.3892\/ol.2016.4647","journal-title":"Oncol Lett"},{"key":"1431_CR25","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1038\/s41388-021-01901-7","volume":"40","author":"X Li","year":"2021","unstructured":"Li X, Wu Z, He J et al (2021) OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP. Oncogene 40:4859\u20134871. https:\/\/doi.org\/10.1038\/s41388-021-01901-7","journal-title":"Oncogene"},{"key":"1431_CR26","doi-asserted-by":"publisher","first-page":"e2216796120","DOI":"10.1073\/pnas.2216796120","volume":"120","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Wang H, Chai S et al (2023) O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation. Proc Natl Acad Sci U S A 120:e2216796120. https:\/\/doi.org\/10.1073\/pnas.2216796120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1431_CR27","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41589-022-01085-5","volume":"18","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Zhou H, Wu L et al (2022) O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1. Nat Chem Biol 18:1087\u20131095. https:\/\/doi.org\/10.1038\/s41589-022-01085-5","journal-title":"Nat Chem Biol"},{"key":"1431_CR28","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1074\/jbc.M115.693580","volume":"291","author":"SP Durning","year":"2016","unstructured":"Durning SP, Flanagan-Steet H, Prasad N, Wells L (2016) O-Linked \u03b2-N-acetylglucosamine (O-GlcNAc) acts as a glucose sensor to Epigenetically regulate the Insulin Gene in pancreatic Beta cells. J Biol Chem 291:2107\u20132118. https:\/\/doi.org\/10.1074\/jbc.M115.693580","journal-title":"J Biol Chem"},{"key":"1431_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0003-9861(03)00234-0","volume":"415","author":"Y Gao","year":"2003","unstructured":"Gao Y, Miyazaki J, Hart GW (2003) The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch Biochem Biophys 415:155\u2013163. https:\/\/doi.org\/10.1016\/s0003-9861(03)00234-0","journal-title":"Arch Biochem Biophys"},{"key":"1431_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12022-014-9347-2","volume":"26","author":"JA Balogun","year":"2015","unstructured":"Balogun JA, Monsalves E, Juraschka K et al (2015) Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr Pathol 26:63\u201370. https:\/\/doi.org\/10.1007\/s12022-014-9347-2","journal-title":"Endocr Pathol"},{"key":"1431_CR31","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1210\/jc.2017-00792","volume":"102","author":"KA \u00d8ystese","year":"2017","unstructured":"\u00d8ystese KA, Casar-Borota O, Normann KR et al (2017) Estrogen receptor \u03b1, a sex-dependent predictor of aggressiveness in nonfunctioning pituitary adenomas: SSTR and sex hormone receptor distribution in NFPA. J Clin Endocrinol Metab 102:3581\u20133590. https:\/\/doi.org\/10.1210\/jc.2017-00792","journal-title":"J Clin Endocrinol Metab"},{"key":"1431_CR32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1210\/endrev\/bnaa006","volume":"41","author":"V Srirangam Nadhamuni","year":"2020","unstructured":"Srirangam Nadhamuni V, Korbonits M (2020) Novel insights into Pituitary Tumorigenesis: genetic and epigenetic mechanisms. Endocr Rev 41:821\u2013846. https:\/\/doi.org\/10.1210\/endrev\/bnaa006","journal-title":"Endocr Rev"},{"key":"1431_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0002-9343(78)90236-x","volume":"64","author":"K Kovacs","year":"1978","unstructured":"Kovacs K, Horvath E, Bayley TA et al (1978) Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. Am J Med 64:492\u2013499. https:\/\/doi.org\/10.1016\/0002-9343(78)90236-x","journal-title":"Am J Med"},{"key":"1431_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1530\/EJE-07-0428","volume":"157","author":"T Tateno","year":"2007","unstructured":"Tateno T, Izumiyama H, Doi M et al (2007) Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Eur J Endocrinol 157:717\u2013724. https:\/\/doi.org\/10.1530\/EJE-07-0428","journal-title":"Eur J Endocrinol"},{"key":"1431_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1507\/endocrj.k07-059","volume":"54","author":"T Tateno","year":"2007","unstructured":"Tateno T, Izumiyama H, Doi M et al (2007) Defective expression of prohormone convertase 1\/3 in silent corticotroph adenoma. Endocr J 54:777\u2013782. https:\/\/doi.org\/10.1507\/endocrj.k07-059","journal-title":"Endocr J"},{"key":"1431_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11102-018-0864-8","volume":"21","author":"A Ben-Shlomo","year":"2018","unstructured":"Ben-Shlomo A, Cooper O (2018) Silent corticotroph adenomas. Pituitary 21:183\u2013193. https:\/\/doi.org\/10.1007\/s11102-018-0864-8","journal-title":"Pituitary"},{"key":"1431_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00000478-200304000-00007","volume":"27","author":"F Roncaroli","year":"2003","unstructured":"Roncaroli F, Scheithauer BW, Young WF et al (2003) Silent corticotroph carcinoma of the adenohypophysis: a report of five cases. Am J Surg Pathol 27:477\u2013486. https:\/\/doi.org\/10.1097\/00000478-200304000-00007","journal-title":"Am J Surg Pathol"},{"key":"1431_CR38","doi-asserted-by":"publisher","first-page":"134407","DOI":"10.1016\/j.neulet.2019.134407","volume":"711","author":"K Makita","year":"2019","unstructured":"Makita K, Takayasu S, Usutani M et al (2019) O-linked \u03b2-N-acetylglucosamine transferase is involved in pro-opiomelanocortin gene expression in mouse pituitary corticotroph AtT-20 cells. Neurosci Lett 711:134407. https:\/\/doi.org\/10.1016\/j.neulet.2019.134407","journal-title":"Neurosci Lett"},{"key":"1431_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1152\/physrev.1999.79.2.511","volume":"79","author":"EE M\u00fcller","year":"1999","unstructured":"M\u00fcller EE, Locatelli V, Cocchi D (1999) Neuroendocrine control of growth hormone secretion. Physiol Rev 79:511\u2013607. https:\/\/doi.org\/10.1152\/physrev.1999.79.2.511","journal-title":"Physiol Rev"},{"key":"1431_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2022.11.006","volume":"131","author":"Y Cui","year":"2023","unstructured":"Cui Y, Cruz M, Palatnik A, Olivier-Van Stichelen S (2023) O-GlcNAc transferase contributes to sex-specific placental deregulation in gestational diabetes. Placenta 131:1\u201312. https:\/\/doi.org\/10.1016\/j.placenta.2022.11.006","journal-title":"Placenta"},{"key":"1431_CR41","doi-asserted-by":"publisher","first-page":"34457","DOI":"10.1074\/jbc.R114.577718","volume":"289","author":"Z Ma","year":"2014","unstructured":"Ma Z, Vosseller K (2014) Cancer metabolism and elevated O-GlcNAc in oncogenic signaling. J Biol Chem 289:34457\u201334465. https:\/\/doi.org\/10.1074\/jbc.R114.577718","journal-title":"J Biol Chem"},{"key":"1431_CR42","doi-asserted-by":"publisher","first-page":"114444","DOI":"10.1016\/j.ejmech.2022.114444","volume":"238","author":"X Li","year":"2022","unstructured":"Li X, Han J, Bujaranipalli S et al (2022) Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 238:114444. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114444","journal-title":"Eur J Med Chem"},{"key":"1431_CR43","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.1021\/acs.jmedchem.9b01090","volume":"62","author":"HG Selnick","year":"2019","unstructured":"Selnick HG, Hess JF, Tang C et al (2019) Discovery of MK-8719, a potent O-GlcNAcase inhibitor as a potential treatment for tauopathies. J Med Chem 62:10062\u201310097. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01090","journal-title":"J Med Chem"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01431-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T23:56:06Z","timestamp":1730850966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01431-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01431-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4350199\/v1","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,27]]},"assertion":[{"value":"10 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure summary"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}